Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, characterized by tumors that are negative for receptors of estrogen, progesterone, and human epidermal growth factor receptor 2 (HER2). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.